Indaptus Therapeutics to Present Positive Data on Lead Product Candidate, Decoy20, at STING & TLR-Targeted Therapies Summit

Go back to Indaptus Therapeutics to Present Positive Data on Lead Product Candidate, Decoy20, at STING & TLR-Targeted Therapies Summit
(NASDAQ: INDP) Delayed: 3.26 -0.29 (8.17%)
Previous Close $3.55    52 Week High
Open $3.58    52 Week Low
Day High $3.65    P/E N/A 
Day Low $3.25    EPS
Volume 94,743